Colon specific drug delivery of mesalamine using eudragit S100-coated chitosan microspheres for the treatment of ulcerative colitis

Authors

  • Seema Badhana Department of Pharmaceutics Institute of Professional Studies College of Pharmacy Gwalior-474001
  • Navneet Garud School of Studies in Pharmaceutical Sciences Jiwaji University Gwalior
  • Akanksha Garud Department of Pharmaceutics Institute of Professional Studies College of Pharmacy Gwalior-474001

DOI:

https://doi.org/10.3329/icpj.v2i3.13577

Keywords:

Ionic-gelation emulsification method, cross-linking, drug release, delivery, particle size, pH dependent

Abstract

The purpose of the present study was to prepare, characterize and evaluate the colon-targeted microspheres of mesalamine for the treatment and management of ulcerative colitis (UC). Microspheres were prepared by the ionic-gelation emulsification method using tripolyphosphate (TPP) as cross linking agent. The microspheres were coated with Eudragit S-100 by the solvent evaporation technique to prevent drug release in the stomach. The prepared microspheres were evaluated for surface morphology, entrapment efficiency, drug loading, micromeritic properties and in-vitro drug release. The microspheres formed had rough surface as observed in scanning electron microscopy. The entrapment efficiency of microspheres ranged from 43.72%-82.27%, drug loading from 20.28%-33.26%. The size of the prepared microspheres ranged between 61.22-90.41µm which was found to increase with increase in polymer concentration. All values are statistically significant as p<0.05. Micromeritic properties showed good flow properties and packability of prepared microspheres. The drug release of mesalamine from microspheres was found to decrease as the polymer concentration increases. The release profile of mesalamine from eudragit-coated chitosan microspheres was found to be pH dependent. It was observed that Eudragit S100 coated chitosan microspheres gave no release in the simulated gastric fluid, negligible release in the simulated intestinal fluid and maximum release in the colonic environment. It was concluded from the study that Eudragit-coated chitosan microspheres were promising carriers for colon-targeted delivery of Mesalamine.

DOI: http://dx.doi.org/10.3329/icpj.v2i3.13577

International Current Pharmaceutical Journal, February 2013, 2(3): 42-48

 

Downloads

Download data is not yet available.
Abstract
2140
PDF
2183

Downloads

Published

2013-02-02

How to Cite

Badhana, S., Garud, N., & Garud, A. (2013). Colon specific drug delivery of mesalamine using eudragit S100-coated chitosan microspheres for the treatment of ulcerative colitis. International Current Pharmaceutical Journal, 2(3), 42–48. https://doi.org/10.3329/icpj.v2i3.13577

Issue

Vol. 2 No. 3 (2013)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).